These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 983356)

  • 1. [The significance of coagulation disorders and the inflammatory reaction in an infectious model of rheumatoid arthritis. II. Inhibition trials with antirheumatic drugs in the inflammatory reaction phase of erysipelas polyarthritis in rats].
    Ehard H; Schulz LC; Mumme J; Weiss R
    Z Rheumatol; 1976; 35(9-10):324-36. PubMed ID: 983356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of coagulation disorders and inflammatory immune reaction in an infectious model of rheumatoid arthritis. I. Systemic, shock-like coagulopathy and fibrin incorporation as indicators of rheumatoid manifestations in the erysipelas model].
    Schulz LC; Hertrampf B; Ehard H; Giese W; Drommer W
    Z Rheumatol; 1976; 35(9-10):315-23. PubMed ID: 983355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats.
    Phadke K; Carroll J; Nanda S
    Clin Exp Immunol; 1982 Mar; 47(3):579-86. PubMed ID: 6979443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental erysipelas in different species as a model for systemic connective tissue disease. II. The chronic phase with special reference to polyarthritis (author's transl)].
    Schulz LC; Drommer W; Seidler D; Ehard H; Leimbeck R; Weiss R
    Beitr Pathol; 1975; 154(1):27-51. PubMed ID: 1122010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antiarthritic compounds on type II collagen-induced arthritis in rats.
    Probert AW; Schrier DJ; Gilbertsen RB
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):167-76. PubMed ID: 6466005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of a rheumatoid model disease using a benzopyron preparation].
    Beuscher N
    Z Rheumatol; 1977; 36(9-10):285-93. PubMed ID: 930424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental erysipelas in different species as a model for systemic connective tissue disease. I. Systemic vascular processes during organ manifestation (author's transl)].
    Schulz LC; Drommer W; Seidler D; Ehard H; Von Mickwitz G; Hertrampf B; Böhm KH
    Beitr Pathol; 1975; 154(1):1-26. PubMed ID: 1092197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the primary lesion of adjuvant. induced polyarthritis in rats (18-hour arthritis test) for specific detection of clinically effective anti-arthritic drugs.
    Sofia RD; Knobloch LC; Vassar HB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):918-31. PubMed ID: 807714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
    Smith RJ; Sly LM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of aspirin, indomethacin and other drugs in adjuvant-induced arthritis in the rat.
    Van Arman CG; Nuss GW; Risley EA
    J Pharmacol Exp Ther; 1973 Nov; 187(2):400-14. PubMed ID: 4748556
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of suprofen in rats with Mycobacterium butyricum-induced arthritis.
    Awouters F; Niemegeers CJ; Lenaerts FM; Janssen PA
    Arzneimittelforschung; 1975 Oct; 25(10):1526-37. PubMed ID: 1243035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive method for the comparative bioassay of nonsteroidal anti-inflammatory compounds in adjuvant-induced primary inflammation in the rat.
    Wax J; Tessman DK; Winder CV; Stephens MD
    J Pharmacol Exp Ther; 1975 Jan; 192(1):166-71. PubMed ID: 1123721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis.
    Francis MD; Hovancik K; Boyce RW
    Int J Tissue React; 1989; 11(5):239-52. PubMed ID: 2517540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of markers of inflammation, arthritis and pain in rats with adjuvant arthritis following the treatment with ibuprofen cream and placebo.
    Rovenský J; Svík K; Istok R; Stancíková M
    Drugs Exp Clin Res; 2003; 29(2):85-90. PubMed ID: 12951839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat adjuvant arthritis as a model to test potential antirheumatic agents.
    Toivonen ML; Tokola O; Vapaatalo H
    Methods Find Exp Clin Pharmacol; 1982; 4(6):359-63. PubMed ID: 7144330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunopathologic aspects of chronic erysipelas polyarthritis in swine].
    Winkelmann J; Trautwein G; Müller-Peddinghaus R; Drommer W; Leibold W; Böhm KH
    Z Rheumatol; 1983; 42(3):91-100. PubMed ID: 6880415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antirheumatic non-steroid drugs in the treatment of rheumatoid arthritis].
    Dormidontov EN; Korshunov NI; Baranova EIa
    Ter Arkh; 1978; 50(9):10-3. PubMed ID: 705637
    [No Abstract]   [Full Text] [Related]  

  • 18. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
    Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
    Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive foot swelling in BUF rats. A new animal model for screening of anti-inflammatory and anti-rheumatic drugs.
    Ishizuki S; Kanda N; Kaneta S; Fujihira E
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):303-14. PubMed ID: 6508437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.
    Mirshafiey A; Cuzzocrea S; Rehm B; Mazzon E; Saadat F; Sotoude M
    Scand J Immunol; 2005 May; 61(5):435-41. PubMed ID: 15882435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.